A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 105; no. 4; pp. e164 - e168
Main Authors Tedeschi, Alessandra, Greil, Richard, Demirkan, Fatih, Robak, Tadeusz, Moreno, Carol, Barr, Paul M., Anz, Bertrand, Simpson, David, Gaidano, Gianluca, Bairey, Osnat, Stevens, Don, Gill, Devinder, Flinn, Ian W., Kipps, Thomas J., Burger, Jan A., Lin, Jennifer, Webb, Thomas, Fedorov, Viktor, Styles, Lori, Gribben, John G.
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.04.2020
Subjects
Adenine - analogs & derivatives
Antibodies, Monoclonal, Humanized - therapeutic use
Chlorambucil - therapeutic use
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Online Only
Piperidines
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
ObjectType-Undefined-2
ISSN:0390-6078
1592-8721
1592-8721
DOI:10.3324/haematol.2019.223743